Xenon Pharmaceuticals Stock Price on December 1, 2024
| XENE Stock | USD 42.63 0.52 1.21% |
Below is the normalized historical share price chart for Xenon Pharmaceuticals extending back to November 05, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Xenon Pharmaceuticals stands at 42.63, as last reported on the 1st of December, with the highest price reaching 43.50 and the lowest price hitting 42.41 during the day.
If you're considering investing in Xenon Stock, it is important to understand the factors that can impact its price. At this point, Xenon Pharmaceuticals is very steady. Xenon Pharmaceuticals shows Sharpe Ratio of 0.0541, which attests that the company had a 0.0541% return per unit of risk over the last 3 months. We have found thirty technical indicators for Xenon Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check out Xenon Pharmaceuticals' Downside Deviation of 2.39, mean deviation of 1.71, and Market Risk Adjusted Performance of 0.0901 to validate if the risk estimate we provide is consistent with the expected return of 0.12%.
At present, Xenon Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 1.3 B, whereas Capital Stock is forecasted to decline to about 783.5 M. . At present, Xenon Pharmaceuticals' Price Sales Ratio is projected to increase significantly based on the last few years of reporting. Xenon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of November 2014 | 200 Day MA 41.3577 | 50 Day MA 41.4052 | Beta 1.251 |
Xenon |
Sharpe Ratio = 0.0541
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | XENE | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.15 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Xenon Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xenon Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 4.0738 | Enterprise Value Ebitda (11.81) | Price Sales 181.4446 | Shares Float 70 M | Wall Street Target Price 57.1825 |
Related Headline
Kronos Bio Headline on 1st of December 2024
Acquisition by Ridloff Elena of 17000 shares of Kronos Bio a... by Ridloff Elena
Filed transaction by Kronos Bio Director. Grant, award or other acquisition pursuant to Rule 16b-3
Xenon Pharmaceuticals Valuation on December 1, 2024
It is possible to determine the worth of Xenon Pharmaceuticals on a given historical date. On December 1, 2024 Xenon was worth 43.17 at the beginning of the trading date compared to the closed value of 42.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Xenon Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Xenon Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Xenon Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Xenon Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 43.17 | 43.50 | 42.41 | 42.63 | 240,694 | |
12/01/2024 | 43.17 | 43.50 | 42.41 | 42.63 | 0.00 |
| Backtest Xenon Pharmaceuticals | | | Xenon Pharmaceuticals History | | | Xenon Pharmaceuticals Valuation | Previous |
Xenon Pharmaceuticals Trading Date Momentum on December 1, 2024
| On December 01 2024 Xenon Pharmaceuticals was traded for 42.63 at the closing time. The top price for the day was 43.50 and the lowest listed price was 42.41 . There was no trading activity during the period 0.0. Lack of trading volume on December 1, 2024 had no short-term effect on price fluctuation. The trading price change against the current closing price is 1.27% . |
Xenon Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Xenon Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Xenon Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Xenon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Xenon Pharmaceuticals Stock history
Xenon Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Xenon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Xenon Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Xenon Pharmaceuticals stock prices may prove useful in developing a viable investing in Xenon Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 66.9 M | 70.2 M | |
| Net Loss | -112.4 M | -106.8 M |
Xenon Pharmaceuticals Quarterly Net Working Capital |
|
Xenon Pharmaceuticals Stock Technical Analysis
Xenon Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Xenon Pharmaceuticals Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Xenon Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Xenon Pharmaceuticals December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Xenon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xenon Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Xenon Pharmaceuticals stock market strength indicators, traders can identify Xenon Pharmaceuticals entry and exit signals to maximize returns
Xenon Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Xenon Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Xenon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Xenon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0481 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0801 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Xenon Stock analysis
When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |